Hacker News Reader

As much as I'd love to see ridiculous parent laws in medicine get under control, I have very little confidence that Lina Kahn would accomplish anything. She doesn't have a great track record. You really need someone with a good background in patent law specifically for pharmaceuticals to take this on

View on HN

Definitely, experience matters. However, I am used to an FTC that turns a blind eye on these Pharma antics. So, as long as FTC takes these kind of cases on, I am all for it. Even the price of generics are way out of line when compared to the generics you get outside of US. Similarly, a lot of Mergers have resulted in fewer competition in the market, leading to rampant price inflation. Federal institutes like FTC need to step up their game here.

I guess increasing awareness on the issue is better than nothing. I've just noticed that she has a gift for identifying problematic industries but struggles to come up with clear criticisms that could translate into pragmatic solutions.

Reply on news.ycombinator.com